|
2000 Journal Article Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive ratsJeffery, Trina K., Bryan-Lluka, Lesley J. and Wanstall, Janet C. (2000). Specific uptake of 5-hydroxytryptamine is reduced in lungs from hypoxic pulmonary hypertensive rats. European Journal of Pharmacology, 396 (2-3), 137-140. doi: 10.1016/S0014-2999(00)00252-1 |
|
2000 Conference Publication Mutations in transmembrane domain (TMD) 5 of the human noradrenaline transporter (hNAT) cause increases in substrate affinities but decreases in inhibitor affinitiesBryan-Lluka, L. J. and Paczkowski, F. A. (2000). Mutations in transmembrane domain (TMD) 5 of the human noradrenaline transporter (hNAT) cause increases in substrate affinities but decreases in inhibitor affinities. Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Conference Publication Cell Type Dependent Regulation of the NA Transporter (NAT) and 5HT Transporter (SERT) by cAMPDunner, E. M. and Bryan-Lluka, L. J. (2000). Cell Type Dependent Regulation of the NA Transporter (NAT) and 5HT Transporter (SERT) by cAMP. The Australasian, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Conference Publication Role of two amino acids in pharmacological differences between human and rat NA transportersBryan-Lluka, L. J. and Paczkowski, F. A. (2000). Role of two amino acids in pharmacological differences between human and rat NA transporters. Joint Meeting of ASCEPT and the British Pharmacological Society, Melbourne, Australia, 25 - 28 April, 2000. Melbourne, Australia: ASCEPT. |
|
2000 Journal Article Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cellsSiebert, G. A., Pond, S. M. and Bryan-Lluka, L. J. (2000). Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 361 (3), 255-264. doi: 10.1007/s002109900202 |
|
2000 Conference Publication Importance of the first intracellular loop in the activity of the human noradrenaline transporter (hNAT)Sucic, S. and Bryan-Lluka, L. J. (2000). Importance of the first intracellular loop in the activity of the human noradrenaline transporter (hNAT). Joint Meeting of ASCEPT and the British Pharmacological Society, Newcastle, Australia, 3 - 6 December, 2000. Melbourne, Australia: ASCEPT. |
|
1999 Journal Article Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cellsBryan-Lluka, Lesley J., Siebert, Gerhard A. and Pond, Susan M. (1999). Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells. Naunyn-Schmiedeberg's Archives of Pharmacology, 360 (2), 109-115. doi: 10.1007/s002109900060 |
|
1999 Journal Article Replacement and reduction of animal usage in teaching physiology and pharmacology at the University of QueenslandLluka, Lesley and Oelrichs, Beverley A. (1999). Replacement and reduction of animal usage in teaching physiology and pharmacology at the University of Queensland. ANZCCART News, 12 (2), 4-7. |
|
1999 Conference Publication Mechanism of 5-HT transporter (SERT) regulation by thyrosinePapacostas, M. and Bryan-Lluka, L. J. (1999). Mechanism of 5-HT transporter (SERT) regulation by thyrosine. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Norepinephrine (NE) transporter (NET) and serotonin (5-HT) transporter (SERT) regulation by thyroxine (T4), angiotensin II (AII) and insulin (INS)Bryan-Lluka, L. J. and Boyd, S. M. (1999). Norepinephrine (NE) transporter (NET) and serotonin (5-HT) transporter (SERT) regulation by thyroxine (T4), angiotensin II (AII) and insulin (INS). 42nd Annual Meeting of the Western Pharmacology Society, Maui, Hawwaii, USA, 30 Jan - 04 Feb, 1999. Seattle, USA: Western Pharacological Society. |
|
1999 Journal Article Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transportersPaczkowski, F. A., Bryan-Lluka, L. J., Porzgen, P., Bruss, M. and Bonisch, H. (1999). Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters. The Journal of Pharmacology and Experimental Therapeutics, 290 (2), 761-767. |
|
1999 Conference Publication Regulation of noradrenaline transporter (NAT) and 5-HT transporter (SERT) activity by inhibitors and substratesBryan-Lluka, L. J., Ha, L. D. Q. and Boyd, S. M. (1999). Regulation of noradrenaline transporter (NAT) and 5-HT transporter (SERT) activity by inhibitors and substrates. 33rd Annual Scientific Meeting of ASCEPT, Sydney Convention & Exhibition Cen., Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Interactions of Haloperidol (HP) Metabolites with transporters for Dopamine (DAT), Norepinephrine (NET) and Serotonin (SERT)Siebert, G. A., Pond, S. M. and Bryan-Lluka, L. J. (1999). Interactions of Haloperidol (HP) Metabolites with transporters for Dopamine (DAT), Norepinephrine (NET) and Serotonin (SERT). 42nd Annual Meeting of the Western Pharmacology Society, Maui, Hawaii, USA, 30 Jan - 04 Feb, 1999. Seattle, USA: Western Pharmacological Society. |
|
1999 Conference Publication Effects of mutation of phenylalanine-531 on rat noradrenaline transporter activityPaczkowski, F. A. and Bryan-Lluka, L. J. (1999). Effects of mutation of phenylalanine-531 on rat noradrenaline transporter activity. 33rd Annual Scientific Meeting of ASCEPT, Sydney, 4 - 8 December, 1999. Melbourne: Blackwell Scientific Publications. |
|
1999 Conference Publication Thyroxine causes cell type-dependent regulation of the serotonin and noradrenaline transportersBryan-Lluka, L. J., Boyd, S. M. and Papacostas, M. H. (1999). Thyroxine causes cell type-dependent regulation of the serotonin and noradrenaline transporters. British Pharmacological Society Meeting, University of Leeds, UK, 8 - 10 September, 1999. Hampshire, UK: Stockton Press - Div. of Macmillan Press Ltd. |
|
1998 Journal Article Catecholamine uptake and metabolism in rat lungsBryan-Lluka, L. J., James, K. M., Bönisch, H., Pörzgen, P., Guice, K. S. and Oldham, K. T. (1998). Catecholamine uptake and metabolism in rat lungs. Advances in pharmacology (San Diego, Calif.), 42, 353-356. |
|
1997 Journal Article The rat norepinephrine transporter: Molecular cloning from PC12 cells and functional expressionBrüss, Michael, Pörzgen, Peter, Bryan-Lluka, Lesley J. and Bönisch, Heinz (1997). The rat norepinephrine transporter: Molecular cloning from PC12 cells and functional expression. Molecular Brain Research, 52 (2), 257-262. doi: 10.1016/S0169-328X(97)00267-2 |
|
1997 Journal Article Catecholamine Uptake and Metabolism in Rat LungsBryan-Lluka, Lesley J., James, Kristy M., Bönisch, Heinz, Pörzgen, Peter, Guice, Karen S. and Oldham, Keith T. (1997). Catecholamine Uptake and Metabolism in Rat Lungs. Advances in Pharmacology, 42 (C), 353-356. doi: 10.1016/S1054-3589(08)60763-2 |
|
1997 Journal Article Efflux studies allow further characterisation of the noradrenaline and 5-hydroxytryptamine transporters in rat lungsJames, K. M. and Bryan-Lluka, L. J. (1997). Efflux studies allow further characterisation of the noradrenaline and 5-hydroxytryptamine transporters in rat lungs. Naunyn-Schmiedeberg's Archives of Pharmacology, 356 (1), 126-133. doi: 10.1007/PL00005019 |
|
1996 Journal Article Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of ratsBryan-Lluka L.J., Seers H. and Sharpe I. (1996). Amezinium and debrisoquine are substrates of uptake1 and potent inhibitors of monoamine oxidase in perfused lungs of rats. Naunyn-Schmiedeberg's Archives of Pharmacology, 353 (5), 536-544. doi: 10.1007/BF00169173 |
